BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18385967)

  • 1. Chemokine-like functions of MIF in atherosclerosis.
    Schober A; Bernhagen J; Weber C
    J Mol Med (Berl); 2008 Jul; 86(7):761-70. PubMed ID: 18385967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
    Bernhagen J; Krohn R; Lue H; Gregory JL; Zernecke A; Koenen RR; Dewor M; Georgiev I; Schober A; Leng L; Kooistra T; Fingerle-Rowson G; Ghezzi P; Kleemann R; McColl SR; Bucala R; Hickey MJ; Weber C
    Nat Med; 2007 May; 13(5):587-96. PubMed ID: 17435771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
    Sinitski D; Kontos C; Krammer C; Asare Y; Kapurniotu A; Bernhagen J
    Thromb Haemost; 2019 Apr; 119(4):553-566. PubMed ID: 30716779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment.
    Weber C; Kraemer S; Drechsler M; Lue H; Koenen RR; Kapurniotu A; Zernecke A; Bernhagen J
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16278-83. PubMed ID: 18852457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism.
    Kraemer S; Lue H; Zernecke A; Kapurniotu A; Andreetto E; Frank R; Lennartz B; Weber C; Bernhagen J
    FASEB J; 2011 Mar; 25(3):894-906. PubMed ID: 21106938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation.
    Brandhofer M; Hoffmann A; Blanchet X; Siminkovitch E; Rohlfing AK; El Bounkari O; Nestele JA; Bild A; Kontos C; Hille K; Rohde V; Fröhlich A; Golemi J; Gokce O; Krammer C; Scheiermann P; Tsilimparis N; Sachs N; Kempf WE; Maegdefessel L; Otabil MK; Megens RTA; Ippel H; Koenen RR; Luo J; Engelmann B; Mayo KH; Gawaz M; Kapurniotu A; Weber C; von Hundelshausen P; Bernhagen J
    Cell Mol Life Sci; 2022 Sep; 79(10):512. PubMed ID: 36094626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.
    Noels H; Bernhagen J; Weber C
    Trends Cardiovasc Med; 2009 Apr; 19(3):76-86. PubMed ID: 19679264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting.
    Kontos C; El Bounkari O; Krammer C; Sinitski D; Hille K; Zan C; Yan G; Wang S; Gao Y; Brandhofer M; Megens RTA; Hoffmann A; Pauli J; Asare Y; Gerra S; Bourilhon P; Leng L; Eckstein HH; Kempf WE; Pelisek J; Gokce O; Maegdefessel L; Bucala R; Dichgans M; Weber C; Kapurniotu A; Bernhagen J
    Nat Commun; 2020 Nov; 11(1):5981. PubMed ID: 33239628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyromonas gingivalis-Induced MIF Regulates Intercellular Adhesion Molecule-1 Expression in EA.hy926 Cells and Monocyte-Endothelial Cell Adhesion Through the Receptors CD74 and CXCR4.
    Wu Y; Xu W; Hou J; Liu Y; Li R; Liu J; Li C; Tang X; Lin L; Pan Y; Zhang D
    Inflammation; 2019 Jun; 42(3):874-883. PubMed ID: 30506423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
    DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC
    Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis.
    Tillmann S; Bernhagen J; Noels H
    Front Immunol; 2013; 4():115. PubMed ID: 23720662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in atherosclerosis: an update.
    Zernecke A; Shagdarsuren E; Weber C
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1897-908. PubMed ID: 18566299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
    Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties.
    Wirtz TH; Tillmann S; Strüßmann T; Kraemer S; Heemskerk JW; Grottke O; Gawaz M; von Hundelshausen P; Bernhagen J
    Atherosclerosis; 2015 Mar; 239(1):1-10. PubMed ID: 25561410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways linking aging and atheroprotection in Mif-deficient atherosclerotic mice.
    Krammer C; Yang B; Reichl S; Besson-Girard S; Ji H; Bolini V; Schulte C; Noels H; Schlepckow K; Jocher G; Werner G; Willem M; El Bounkari O; Kapurniotu A; Gokce O; Weber C; Mohanta S; Bernhagen J
    FASEB J; 2023 Mar; 37(3):e22752. PubMed ID: 36794636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A MIF-Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2.
    Krammer C; Kontos C; Dewor M; Hille K; Dalla Volta B; El Bounkari O; Taş K; Sinitski D; Brandhofer M; Megens RTA; Weber C; Schultz JR; Bernhagen J; Kapurniotu A
    Chembiochem; 2021 Mar; 22(6):1012-1019. PubMed ID: 33125165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
    Klasen C; Ohl K; Sternkopf M; Shachar I; Schmitz C; Heussen N; Hobeika E; Levit-Zerdoun E; Tenbrock K; Reth M; Bernhagen J; El Bounkari O
    J Immunol; 2014 Jun; 192(11):5273-84. PubMed ID: 24760155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
    Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
    Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4.
    Lacy M; Kontos C; Brandhofer M; Hille K; Gröning S; Sinitski D; Bourilhon P; Rosenberg E; Krammer C; Thavayogarajah T; Pantouris G; Bakou M; Weber C; Lolis E; Bernhagen J; Kapurniotu A
    Sci Rep; 2018 Mar; 8(1):5171. PubMed ID: 29581527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis.
    Baba O; Huang LH; Elvington A; Szpakowska M; Sultan D; Heo GS; Zhang X; Luehmann H; Detering L; Chevigne A; Liu Y; Randolph GJ
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):822-836. PubMed ID: 33327748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.